Clinical Trials Logo

Follicular Thyroid Cancer clinical trials

View clinical trials related to Follicular Thyroid Cancer.

Filter by:
  • Active, not recruiting  
  • Page 1

NCT ID: NCT04544111 Active, not recruiting - Thyroid Cancer Clinical Trials

PDR001 Combination Therapy for Radioiodine-Refractory Thyroid Cancer

Start date: September 2, 2020
Phase: Phase 2
Study type: Interventional

The purpose of this study is to find out whether a drug called PDR001, combined with either trametinib or dabrafenib, is a safe and effective treatment for thyroid cancer.

NCT ID: NCT01723202 Active, not recruiting - Clinical trials for Papillary Thyroid Cancer

Dabrafenib With or Without Trametinib in Treating Patients With Recurrent Thyroid Cancer

Start date: November 7, 2012
Phase: Phase 2
Study type: Interventional

This randomized phase II trial studies how well dabrafenib works with or without trametinib in treating patients with recurrent thyroid cancer. Dabrafenib and trametinib may stop the growth of tumor cells by blocking some of the enzymes needed for cell growth. It is not yet known whether dabrafenib is more effective when given with or without trametinib in treating thyroid cancer